GLP1R and diabetic kidney disease: Strong evidence is presented in this meta-analysis in favor of GLP-1 receptor agonists as a useful therapeutic option for maintaining renal function in patients with T2DM, particularly in those who are at high risk of developing DKD or who already have it.